Subspecialty internal medicine in the United States: in and outside the hospital.

Schweiz Med Wochenschr

American Board of Internal Medicine, Philadelphia, PA 19106-3699, USA.

Published: December 1999

In the U.S. the subspecialties of internal medicine are well integrated in the overall discipline of internal medicine and each one is also unique. The American Board of Internal Medicine at present certifies 16 unique subdisciplines, which are, in order from the largest to the smallest: cardiology (14,000 certified cardiologists), gastroenterology (10,000 certified), pulmonary disease (9000 certified), critical care medicine (6500 certified), hematology, oncology, nephrology, infectious diseases, allergy and immunology, endocrinology, rheumatology, geriatrics, sport medicine, adolescent medicine. General internal medicine is the first level of certification after three years of training: the above-mentioned subspecialties are the second level (after an additional 2 to 3 years of training). Some subspecialties are at a third level or "third tier". Within cardiology, "third tier" certification recognizes clinical cardiac electrophysiology and interventional cardiology. These disciplines require an additional, fourth year of cardiac training and prior certification in cardiology. Between the departments of internal medicine and the subspecialty divisions there is often a "healthy tension" stemming from unavoidable inequities in the financial contributions of the subspecialties to the department. Currently, there is a decline in specialization rate due to a variety of converging factors, among them restricted direct access to specialists in HMOs, and the developing hospitalist movement: full-time hospitalists are less likely to need subspecialist consultation than other generalists.

Download full-text PDF

Source

Publication Analysis

Top Keywords

internal medicine
24
medicine
9
years training
8
"third tier"
8
internal
5
subspecialty internal
4
medicine united
4
united states
4
states hospital
4
subspecialties
4

Similar Publications

Importance: Endocrine treatments, such as Tamoxifen (TAM) and/or Aromatase inhibitors (AI), are the adjuvant therapy of choice for hormone-receptor positive breast cancer. These agents are associated with menopausal symptoms, adversely affecting drug compliance. Topical estrogen (TE) has been proposed for symptom management, given its' local application and presumed reduced bioavailability, however its oncological safety remains uncertain.

View Article and Find Full Text PDF

Aggressive angiomyxoma of the vagina: A case report and literature review.

Medicine (Baltimore)

January 2025

Department of Internal Medicine, Division of Hematology and Oncology, Jeonbuk National University Hospital, Jeonbuk National University Medical School, Jeonju, Republic of Korea.

Rationale: Aggressive angiomyxoma (AAM) is an exceptionally rare mesenchymal tumor that predominantly manifests in the female genital organs during the reproductive age. Its rarity alone makes it a fascinating subject for study. The diagnosis of AAM necessitates differentiation from other benign or mesenchymal tumors and can be confirmed through immunohistochemistry (IHC) staining.

View Article and Find Full Text PDF

Torsion and ruptured ovarian cystadenocarcinoma with internal bleeding complicated with retroperitoneal hematoma after tumor transection: A case report.

Medicine (Baltimore)

January 2025

Department of Obstetrics and Gynecology, Minimally Invasive Gynecology Surgery Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.

Rationale: Ovarian tumor torsion is a critical gynecological emergency, predominantly affecting women of reproductive age, with benign teratomas being the most common culprits. In contrast, malignant ovarian tumors, such as mucinous cystadenocarcinoma, infrequently present with torsion due to their invasive and angiogenic characteristics. The occurrence of torsion in malignant tumors complicates diagnosis and management, particularly when associated with complications like congestion, infarction, and internal bleeding.

View Article and Find Full Text PDF

Background: This study investigates the therapeutic efficacy of dynamic neuromuscular stabilization (DNS) technology paired with Kinesio Taping in patients with persistent nonspecific low back pain, as well as the effect on neuromuscular function and pain self-efficacy.

Methods: A randomized controlled clinical study was conducted to collect clinical data on DNS combined with KT for the treatment of chronic nonspecific low back pain from November 2023 to April 2024. The inclusion criteria were patients with chronic nonspecific lower back pain, aged between 18 and 30 years old, and without serious underlying medical conditions, such as cardiac disease, hypertension, and diabetes.

View Article and Find Full Text PDF

Background: Sepsis, a critical global health challenge, accounted for approximately 20% of worldwide deaths in 2017. Although the Sequential Organ Failure Assessment (SOFA) score standardizes the diagnosis of organ dysfunction, early sepsis detection remains challenging due to its insidious symptoms. Current diagnostic methods, including clinical assessments and laboratory tests, frequently lack the speed and specificity needed for timely intervention, particularly in vulnerable populations such as older adults, intensive care unit (ICU) patients, and those with compromised immune systems.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!